APA (7th ed.) Citation

M, I., Y, H., R, W., K, A., A, Y., K, N., . . . T, I. (2025). Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study. Cancer diagnosis & prognosis, 5(4), 492. https://doi.org/10.21873/cdp.10463

Chicago Style (17th ed.) Citation

M, Iwai, Horimoto Y, Wu R, Amaya K, Yamada A, Narui K, Yamada K, Kaise H, and Ishikawa T. "Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study." Cancer Diagnosis & Prognosis 5, no. 4 (2025): 492. https://doi.org/10.21873/cdp.10463.

MLA (9th ed.) Citation

M, Iwai, et al. "Clinical Significance of HER2-low Expression in Triple-negative Breast Cancer: A Retrospective Multicenter Study." Cancer Diagnosis & Prognosis, vol. 5, no. 4, 2025, p. 492, https://doi.org/10.21873/cdp.10463.